David E. Watson

1.0k total citations
22 papers, 759 citations indexed

About

David E. Watson is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, David E. Watson has authored 22 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in David E. Watson's work include Viral Infections and Immunology Research (4 papers), Environmental Toxicology and Ecotoxicology (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). David E. Watson is often cited by papers focused on Viral Infections and Immunology Research (4 papers), Environmental Toxicology and Ecotoxicology (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). David E. Watson collaborates with scholars based in United States, Singapore and Dominican Republic. David E. Watson's co-authors include Rudolf Brenneisen, Mahmoud A. ElSohly, Salvatore J. Salamone, Timothy P. Murphy, Stefan Russmann, Mark A. Deeg, Ayad K. Ali, Bruce M. Hasspieler, Richard T. Di Giulio and David B. Carlson and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

David E. Watson

22 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Watson United States	16	267	173	155	100	86	22	759
Jeffrey P. Walterscheid United States	19	314 1.2×	47 0.3×	101 0.7×	217 2.2×	39 0.5×	31	1.3k
Simon W. Walker United Kingdom	19	280 1.0×	146 0.8×	146 0.9×	13 0.1×	65 0.8×	44	887
Waldemar B. Minich Germany	19	774 2.9×	238 1.4×	43 0.3×	12 0.1×	175 2.0×	43	1.7k
Thomas Wendl Germany	14	243 0.9×	114 0.7×	43 0.3×	12 0.1×	92 1.1×	24	998
Cristina Gómez Spain	18	234 0.9×	336 1.9×	62 0.4×	25 0.3×	26 0.3×	36	906
H. Roger Brown United States	12	381 1.4×	49 0.3×	52 0.3×	22 0.2×	36 0.4×	22	696
Malcolm J. York United Kingdom	18	245 0.9×	38 0.2×	49 0.3×	15 0.1×	98 1.1×	29	1.1k
Suk Ju Cho South Korea	14	220 0.8×	37 0.2×	69 0.4×	17 0.2×	50 0.6×	30	556
Shozo Nakazawa Japan	17	309 1.2×	105 0.6×	99 0.6×	24 0.2×	23 0.3×	81	1.0k
M Hirst United States	5	272 1.0×	235 1.4×	47 0.3×	12 0.1×	50 0.6×	8	768

Countries citing papers authored by David E. Watson

Since Specialization

Citations

This map shows the geographic impact of David E. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Watson more than expected).

Fields of papers citing papers by David E. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Watson. The network helps show where David E. Watson may publish in the future.

Co-authorship network of co-authors of David E. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Watson. A scholar is included among the top collaborators of David E. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Watson. David E. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mulrooney‐Cousins, Patricia M., et al.. (2022). Identification of antibodies cross-reactive with woodchuck immune cells and activation of virus-specific and global cytotoxic T cell responses by anti-PD-1 and anti-PD-L1 in experimental chronic hepatitis B and persistent occult hepadnaviral infection. Frontiers in Microbiology. 13. 1011070–1011070. 4 indexed citations

Milliken, Philip H., Mike Aylott, Steven K. Engle, et al.. (2020). Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative. Toxicological Sciences. 176(1). 224–235. 4 indexed citations

Ali, Ayad K. & David E. Watson. (2017). Pharmacovigilance Assessment of Immune‐Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(11). 1383–1390. 30 indexed citations

Burch, Peter M., Elizabeth G. Walker, William M. Bracken, et al.. (2015). Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats. Toxicological Sciences. 150(1). 247–256. 35 indexed citations

Jordan, William H., et al.. (2014). Initial Biological Qualification of SBDP-145 as a Biomarker of Compound-Induced Neurodegeneration in the Rat. Toxicological Sciences. 141(2). 398–408. 5 indexed citations

Usborne, Amy, Aaron T. Smith, Steven K. Engle, et al.. (2013). Biomarkers of Exocrine Pancreatic Injury in 2 Rat Acute Pancreatitis Models. Toxicologic Pathology. 42(1). 195–203. 25 indexed citations

Woude, Aniek D. van der, Annabel Parret, Roy Ummels, et al.. (2012). Specific Chaperones for the Type VII Protein Secretion Pathway. Journal of Biological Chemistry. 287(38). 31939–31947. 66 indexed citations

Sloan, John H., et al.. (2012). A novel high-sensitivity electrochemiluminescence (ECL) sandwich immunoassay for the specific quantitative measurement of plasma glucagon. Clinical Biochemistry. 45(18). 1640–1644. 21 indexed citations

Sutherland, Jeffrey J., John W. Raymond, James Stevens, Thomas K. Baker, & David E. Watson. (2012). Relating Molecular Properties and in Vitro Assay Results to in Vivo Drug Disposition and Toxicity Outcomes. Journal of Medicinal Chemistry. 55(14). 6455–6466. 42 indexed citations

10.

Mallela, Jaya, et al.. (2010). Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase. Biochemical and Biophysical Research Communications. 405(3). 338–343. 18 indexed citations

11.

Butterfield, Anthony, et al.. (2009). Electrochemiluminescent immunoassay for rat skeletal troponin I (Tnni2) in serum. Journal of Pharmacological and Toxicological Methods. 61(1). 52–58. 8 indexed citations

12.

Engle, Steven K., Philip F. Solter, Kelly M. Credille, et al.. (2009). Detection of Left Ventricular Hypertrophy in Rats Administered a Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Using Natriuretic Peptides and Imaging. Toxicological Sciences. 114(2). 183–192. 23 indexed citations

13.

Engle, Steven K., William H. Jordan, Alan Y. Chiang, et al.. (2009). Qualification of Cardiac Troponin I Concentration in Mouse Serum Using Isoproterenol and Implementation in Pharmacology Studies to Accelerate Drug Development. Toxicologic Pathology. 37(5). 617–628. 35 indexed citations

14.

Recknor, Justin, et al.. (2008). Fabp3 as a Biomarker of Skeletal Muscle Toxicity in the Rat: Comparison with Conventional Biomarkers. Toxicological Sciences. 103(2). 382–396. 38 indexed citations

15.

Zhen, Yuejun, Michael J. Berna, Zhiying Jin, et al.. (2007). Quantification of heart fatty acid binding protein as a biomarker for drug‐induced cardiac and musculoskeletal necroses. PROTEOMICS - CLINICAL APPLICATIONS. 1(7). 661–671. 18 indexed citations

16.

Brenneisen, Rudolf, Mahmoud A. ElSohly, Timothy P. Murphy, et al.. (2004). Pharmacokinetics and Excretion of Gamma-Hydroxybutyrate (GHB) in Healthy Subjects. Journal of Analytical Toxicology. 28(8). 625–630. 116 indexed citations

17.

Watson, David E.. (1997). Hepatic CYP1A in brown bullhead catalyzes the binding of 2-aminoanthracene to DNA in vivo and in vitro. Aquatic Toxicology. 37(1). 21–36. 11 indexed citations

18.

Watson, David E., et al.. (1995). Aminoanthracene Is a Mechanism-Based Inactivator of CYP1A in Channel Catfish Hepatic Tissue. Toxicology and Applied Pharmacology. 135(2). 208–215. 21 indexed citations

19.

Giulio, Richard T. Di, et al.. (1995). Determinants of species susceptibility to oxidative stress: A comparison of channel catfish and brown bullhead. Marine Environmental Research. 39(1-4). 175–179. 18 indexed citations

20.

Hasspieler, Bruce M., et al.. (1994). Susceptibility of channel catfish (Ictalurus punctatus) and brown bullhead (Ameriurus nebulosus) to oxidative stress: a comparative study. Aquatic Toxicology. 28(1-2). 53–64. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact